
                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

               Date of Report (Date of earliest event reported):
                                  July 29, 2003

                            PHASE III MEDICAL, INC.
                            -----------------------
             (Exact name of registrant as specified in its charter)

                                    Delaware
                                    --------
                 (State or other jurisdiction of incorporation)

                  0-10909                                    22-2343568
           ----------------------------------------------------------------
           Commission File Number                           IRS Employer
                                                         Identification No.

330 SOUTH SERVICE ROAD, SUITE 120, Melville, New York           11747
--------------------------------------------------------------------------------
     (Address of principal executive offices)                 (Zip Code)

                                  631-574-4955
                                  ------------
                          Registrant's Telephone Number

                           CORNICHE GROUP INCORPORATED
                           ---------------------------
         (Former name or former address, if changed since last report.)


<PAGE>

ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE

      Phase III  Medical,  Inc.  (formerly  Corniche  Group  Incorporated)  (the
"Company")  issued the press release  annexed  hereto  announcing  its new stock
symbols reflecting its new corporate name.

                                    * * * * *

This Report contains forward-looking statements made pursuant to the safe harbor
provisions   of  the  Private   Securities   Litigation   Reform  Act  of  1995.
Forward-looking  statements  represent  management's  judgment  regarding future
events.  Although  management  believes that the expectations  reflected in such
statements are reasonable,  they give no assurance that such  expectations  will
prove to be correct and you should be aware that  actual  results  could  differ
materially  from those  contained  in the  forward-looking  statements  due to a
number of factors.  These  factors  include  the risk that the  Company  will be
unable to raise capital,  to enter successfully or exploit  opportunities in the
biotech  or  medical  business,  to have  appropriate  personnel,  or the  risks
inherent in any new business  venture or those  detailed in the Company's  other
reports  filed  with  the  Securities  and  Exchange  Commission.   The  Company
undertakes no obligation to update or revise the  information  contained in this
Report whether as a result of new information, future events or circumstances or
otherwise.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

Exhibit 99.1      Press Release


                                      -2-
<PAGE>

                                    SIGNATURE

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                                     PHASE III MEDICAL, INC.

                                                     By: /s/ Mark Weinreb
                                                         -----------------------
                                                         Mark Weinreb
                                                         President

      Dated: July 29, 2003


                                      -3-

